Send us a link
In times of crisis, we need community. With schools, colleges and universities mandating online teaching and learning in response to COVID-19, often with only a week of preparation time, people are scrambling for resources and information.
The explosive spread of coronavirus can be turned to our advantage, two infectious disease experts argue: "But only if we intervene early. That means now."
An informational briefing on COVID-19.
Ready to stop asking yourself, what is a peer review in science? Allow us to enlighten you. Here is your complete guide!
A simple graph illustrates the power of exponential growth in infectious times and how individuals can affect change.
The country is not aiming for 60 percent of the populace to get COVID-19, but you'd be forgiven for thinking so based on how badly the actual plan has been explained.
Estimation of the prevalence and contagiousness of undocumented novel coronavirus (SARS-CoV2) infections is critical for understanding the overall prevalence and pandemic potential of this disease. Here we use observations of reported infection within China to infer critical epidemiological characteristics associated with SARS-CoV2, including the fraction of undocumented infections and their contagiousness.
Giving the keynote address at the 2020 Centre for Science and Policy Annual Lecture, Dame Sally shared her behind-the-scenes account of her work on antimicrobial resistance (AMR) as the UK’s Chief Medical Officer, while reflecting on what it takes to get the right science to inform the right policy questions at the right time.
How do government, public policy development processes, and science interact? How can scientists engage with the policy world? How do politics, evidence and the logistics of delivery play into policymaking decisions?
Government science advisers in a dozen countries are asking scientific journals to make data on the disease more widely available.
The future European Open Science Cloud (EOSC) can be the answer to societal challenges as they emerge. The goal of EOSC is to open up all scientific data and publications and combine the results to drive new discoveries and tackle key societal challenges.
Scientists are rapidly analyzing genetic samples from infected patients and sharing the data. But to move too fast is to risk making mistakes.
In recent years traditional journalism has experienced a collapse, and science journalism has been a major casualty. This study suggests that filling the science news void by scientists as science reporters leads to normal levels of audience engagement.
A qualitative assessment to identify good practices, capacity gaps and investment priorities, whose results could serve as strategic investment targets for the joint efforts of national governments and international organisations that fund programmes for strengthening research capacity in low- and middle-income countries.
Gestern Donnerstag haben 25 Forschende aus der Schweiz den Bundesrat aufgefordert zur Linderung der Corona-Epidemie "einschneidende ...
The Coronavirus pandemic sends students around the world home from university campuses and into online courses.
As the Board of Reviewing Editors reaches 500, we reflect on recent recruitment efforts.
A team member on the huge project has tested positive for the virus, delaying the air mission.
Many of these titles have some editorial oversight - but the quality of reviews is in question.
While the characteristics of scholars who publish in predatory journals are relatively well-understood, nothing is known about the scholars who review for these journals. This article aims to shed light on the reviewers for predatory journals.
A researcher who forecasts epidemic spread argues that proactive closures, though disruptive, could help.
Universities and research organisations have joined forces to develop a new interactive tool that explores how free movement has affected EU economies and societies.
Research charities Wellcome Trust and the Gates Foundation announced they are joining forces with the credit card company MasterCard in a $125 million push to speed up development of drugs for treating COVID-19 infections, in the latest example of the rush to fund research into the novel coronavirus.
